The assistant professor of neurology at the University of Virginia spoke at the 2022 American Epilepsy Society Annual Meeting about clinical outcomes of patients with dementia who experience seizures.
This video originally appeared on NeurologyLive. The summary below has been lightly edited.
Recent research has proven a strong association between seizures and dementia, as findings have shown the high impact seizures have on clinical and mortality outcomes. As patients with epilepsy experience symptoms of cognitive decline, patients with dementia are similarly at a high risk of developing seizures. In addition, seizures have been often associated with more severe cognitive impairment among patients with dementia.
Recently, Ifrah Zawar, MD, presented an abstract on the clinical outcomes of patients who experience both seizures and dementia during a poster session at the 2022 American Epilepsy Society Annual Meeting, held December 2-6, in Nashville, Tennessee. In her presentation, she provided an overview of the study, in which results demonstrated that patients with active seizures and dementia at a younger age have worse cognition, poorer function, and higher mortality rates compared with patients who have dementia without seizures.
At the meeting, Zawar, assistant professor of neurology at the University of Virginia, sat down with NeurologyLive® for an interview and offered a summary about the current knowns and unknowns about epilepsy and seizures in those with dementia. She also explained the most important aspect of care and the most recent advances of care for patients in this specific population. Zawar provided detail on the previous research that has revealed the knowledge gaps between epilepsy and dementia.
Reference
Zawar I. Seizures in dementia associated with worse clinical outcomes, higher mortality rates and shorter lifespan. Presented at: AES Annual Meeting; December 2-6, 2022; Nashville, TN, and virtual.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen